Endometrial miR-181a and miR-98 Expression Is Altered during Transition from Normal into Cancerous State and TargetPGR,PGRMC1,CYP19A1,DDX3X, andTIMP3
Author(s) -
Harekrushna Panda,
TsaiDer Chuang,
Xiaoping Luo,
Nasser Chegini
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-1018
Subject(s) - progesterone receptor , microrna , endometrial cancer , medicine , endocrinology , follicular phase , endometrium , cancer research , medroxyprogesterone acetate , biology , transfection , estrogen receptor , estrogen , chemistry , cell culture , cancer , gene , breast cancer , biochemistry , genetics
Evidence suggests that a number of microRNA (miRNA) are aberrantly expressed in endometrial disorders with potential posttranscriptional regulation of their specific target genes, including ovarian steroid receptors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom